4//SEC Filing
Lis William 4
Accession 0001013762-23-003901
CIK 0001788028other
Filed
Oct 12, 8:00 PM ET
Accepted
Oct 13, 6:56 PM ET
Size
5.4 KB
Accession
0001013762-23-003901
Insider Transaction Report
Form 4
Lis William
DirectorChief Executive Officer
Transactions
- Sale
Voting Common Stock
2023-10-13$0.85/sh−7,965$6,777→ 53,521 total
Footnotes (2)
- [F1]The transaction reported in this Form 4 was effected pursuant to a trading plan intended to comply with Rule 10b5-1(c) and adopted by the Reporting Person on June 15, 2023.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.84 to $0.8717, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
Documents
Issuer
Jasper Therapeutics, Inc.
CIK 0001788028
Entity typeother
Related Parties
1- filerCIK 0001574558
Filing Metadata
- Form type
- 4
- Filed
- Oct 12, 8:00 PM ET
- Accepted
- Oct 13, 6:56 PM ET
- Size
- 5.4 KB